Literature DB >> 564266

The use of netropsin with CsCl gradients for the analysis of DNA and its application to restriction nuclease fragments of ribosomal DNA from Physarum polycephalum.

H R Matthews, E M Johnson, W M Steer, E M Bradbury, V G Allfrey.   

Abstract

Netropsin binds to DNA in caesium chloride density gradients and reduces the density of the DNA. The DNA is saturated at a netropsin/DNA weight ratio of about 6 and the change in density, deltarho, at saturation is given by deltarho = -109 (dA + dT content)1.87 mg/ml for the six DNAs tested covering dA + dT contents from 0.28 to 0.69. At lower netropsin/DNA ratios the observed density shifts are consistent with a two-site model for netropsin binding to DNA. Netropsin approximately doubles the resolution of Physarum polycephalum nucleolar satellite DNA from main-band DNA. The fragments of P. polycephalum nucleolar satellite DNA obtained with the restriction endonuclease HindIII do not separate on CsCl gradients, even in the presence of netropsin, which shows that the transcribed and non-transcribed sequences in this DNA have similar nucleotide compositions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564266     DOI: 10.1111/j.1432-1033.1978.tb12052.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Antibiotic induced electrophoretic mobility shifts of DNA restriction fragments.

Authors:  E Loucks; G Chaconas; R W Blakesley; R D Wells; J H van de Sande
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

2.  Excision of pyrimidine dimers from nuclear deoxyribonucleic acid in ultraviolet-irradiated Dictyostelium discoideum.

Authors:  J M Clark; R A Deering
Journal:  Mol Cell Biol       Date:  1981-02       Impact factor: 4.272

3.  Influence of nucleotide sequence on dA.dT-specific binding of Netropsin to double stranded DNA.

Authors:  C Zimmer; C Marck; C Schneider; W Guschlbauer
Journal:  Nucleic Acids Res       Date:  1979-06-25       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.